Artiva Biotherapeutics, Inc. ($ARTV)
Filing Information
| Accession Number | 0001231919-26-000491 |
|---|---|
| Form Type | 4 |
| Filing Date | May 13, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
8,680,554
Total Value
$99,999,765.07
P&L
-25.8% ($25,781,028.37)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 11, 2026 | Purchase | 6,510,416 | $11.52 | $74,999,992.32 | 15,203,995 | Indirect | See footnotes | View Details | |
Director | Pre-Funded Warrant (Right to Buy) | Derivative | May 11, 2026 | Purchase | 2,170,138 | $11.52 | $24,999,772.75 | 2,170,138 | Indirect | See footnotes | View Details |